Speak Now...
Cabozantinib
849217-68-1
C28H24FN3O5
Hepatic Impairment; Hepatocellular Carcinoma; Melanoma; Renal Cell Cancer; Renal Cell Carcinoma
Digestive System Disease; Oncology
Launched
Albania
United Kingdom
Greece
Spain
Luxembourg
Centralized Registered
Decentralized Registered
UK Parallel Import Licence
Veterinary Registered